All Pharma News
CSL Behring cuts headcount by 65 at Illinois plant

CSL Behring cuts headcount by 65 at Illinois plant
Zoey Becker FIERCE PHARMA
15 Apr 2024
Share Share
Kyowa`s Orchard hopes $4.25M gene therapy price tag bears fruit

Kyowa`s Orchard hopes $4.25M gene therapy price tag bears fruit
Fraiser Kansteiner FIERCE PHARMA
20 Mar 2024
Share Share
CSL and uniQure unveil three-year data for one-time hemophilia B gene therapy

CSL and uniQure unveil three-year data for one-time hemophilia B gene therapy
ENDPTS
09 Feb 2024
Share Share
CSL Behring Announces Availability of Hizentra 10g Prefilled Syringe

CSL Behring Announces Availability of Hizentra 10g Prefilled Syringe
PR NEWSWIRE
03 Jan 2024
Share Share
CSL Behring Demonstrates Continued Commitment to Alpha-1 Community

CSL Behring Demonstrates Continued Commitment to Alpha-1 Community
PR NEWSWIRE
02 Jan 2024
Share Share
FDA, EMA accept Pfizer`s hemophilia B gene therapy

FDA, EMA accept Pfizer`s hemophilia B gene therapy
Paul Schloesser ENDPTS
27 Jun 2023
Share Share
CSL doses first patient with haemophilia B gene therapy Hemgenix

CSL doses first patient with haemophilia B gene therapy Hemgenix
Aidan McNamee PHARMACEUTICAL TECHNOLOGY
21 Jun 2023
Share Share
CSL`s Hemgenix (Etranacogene Dezaparvovec) Receives Approval in Europe

CSL`s Hemgenix (Etranacogene Dezaparvovec) Receives Approval in Europe

EMA
20 Jun 2023
Share Share
CSL Behring Announces the First Patient Has Received FDA-Approved HEMGENIX

CSL Behring Announces the First Patient Has Received FDA-Approved HEMGENIX
PR NEWSWIRE
20 Jun 2023
Share Share
CSL Behring Receives FDA Approval for Hizentra®

CSL Behring Receives FDA Approval for Hizentra®
PR NEWSWIRE
18 Apr 2023
Share Share